Table 3.

Agreement between CT and MRI sequences for the detection of lung abnormalities

	CT and B-FFE	CT and T1W	CT and T2W
Consolidation	κ=0.950, P < 0.001	κ=0.950, P < 0.001	κ=0.950, P < 0.001
Patchy increased density	κ=1, P < 0.001	κ=1, P < 0.001	κ=1, P < 0.001
Ground glass opacity	κ=0.565, P < 0.001	κ=0.701, P < 0.001	κ=0.701, P < 0.001
Cavity	κ=0.773, P < 0.001	κ=0.773, P < 0.001	κ=0.773, P < 0.001
Tree-in-bud nodules	κ=0.178, P = 0.048	κ=0.178, P = 0.048	κ=0.178, P = 0.048
Centrilobular nodules	κ=0.113, P = 0.122	κ=0.113, P = 0.122	κ=0.113, P = 0.122
Bronchodilation	κ=0.643, P < 0.001	κ=0.844, P < 0.001	κ=0.844, P < 0.001
Peribronchial thickening	κ=0.724, P < 0.001	κ=0.875, P < 0.001	κ=0.724, P < 0.001
Pleural effusion	κ=0.870, P < 0.001	κ=0.870, P < 0.001	κ=0.870, P < 0.001
Pleural thickening	κ=0.787, P < 0.001	κ=0.787, P < 0.001	κ=0.787, P < 0.001
Pericardial effusion	κ=1, P < 0.001	κ=1, P < 0.001	κ=1, P < 0.001
Halo sign	κ=0.318, P = 0.006	κ=0.808, P < 0.001	κ=0.875, P < 0.001
Air-crescent sign	κ=0.375, P = 0.002	κ=0.643, P < 0.001	κ=0.643, P < 0.001
Reverse halo sign	κ=1, P < 0.001	κ=1, P < 0.001	κ=1, P < 0.001
Total nodule	κ=0.522, P < 0.001	κ=0.662, P < 0.001	κ=0.662, P < 0.001
Nodule <5 mm	κ=0.226, P = 0.024	κ=0.261, P = 0.014	κ=0.297, P = 0.008
Nodule 5–10 mm	κ=0.744, P < 0.001	κ=0.787, P < 0.001	κ=0.787, P < 0.001
Nodule 10–20 mm	κ=0.896, P < 0.001	κ=0.948, P < 0.001	κ=0.948, P < 0.001
Nodule >20 mm	κ=0.844, P < 0.001	κ=0.844, P < 0.001	κ=0.844, P < 0.001

CT, computed tomography; MRI, magnetic resonance imaging; B-FFE, balanced fast field echo; T1W, T1-weighted imaging; T2W, T2-weighted imaging.